SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences informs about newspaper clipping

27 Jul 2024 Evaluate

In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Hester Biosciences has informed that it enclosed a copy of each newspaper clipping of the advertisement published on 27 July 2024 on Notice of 37th Annual General Meeting, Book Closure Period, Dividend details and e-voting information to Members, in Ahmedabad edition of the newspapers: Financial Express (English), and Financial Express (Gujarati).

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1492.80 20.80 (1.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×